This inventor holds 6 USPTO granted patents and 3 published patent applications. Top assignees: Veloxis Pharmaceuticals A/s, Veloxis Pharmaceuticals Inc.. Active years: 2014-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2024
Title: **Innovator Spotlight: Anne-Marie Lademann**
Introduction
Anne-Marie Lademann is a notable inventor based in Klampenborg, Denmark. With six patents to her name, she has made significant contributions to the field of pharmaceuticals, particularly in the area of transplant patient care. Her innovative work focuses on improving medication delivery systems to enhance patient outcomes.
Latest Patents
Lademann's latest patents revolve around tacrolimus, an essential immunosuppressive drug used primarily in kidney and liver transplant patients. She has developed an extended-release oral dosage form that allows for once-daily administration. This formulation includes a unique release mechanism that extends the active substance's release over time, leading to improved pharmacokinetic parameters. These enhancements result in reduced peak concentrations, increased bioavailability, and prolonged times for achieving maximal concentration compared to conventional immediate-release formulations.
Career Highlights
Throughout her career, Lademann has worked with reputable organizations, including Veloxis Pharmaceuticals A/S and Veloxis Pharmaceuticals Inc. Her efforts have not only advanced pharmaceutical innovation but have also addressed critical patient needs in the transplant community. Her extensive work on tacrolimus formulations exemplifies her dedication to improving health outcomes through scientific innovation.
Collaborations
Lademann has collaborated with notable colleagues such as Robert D. Gordon and Per Holm. These partnerships reflect her ability to work effectively within interdisciplinary teams, combining expertise to drive innovation forward.
Conclusion
Anne-Marie Lademann's contributions to pharmaceuticals and patient care underscore the importance of research and innovation in medicine. Through her patents and collaborative efforts, she continues to make strides in improving treatment options for transplant patients, demonstrating the profound impact that dedicated inventors can have on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile